Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
British Journal of Cancer|March 15, 2012
Mutation analysis of RAD51D in non-BRCA1/2 ovarian and breast cancer familiesD J Osher, K De Leeneer, G Michils, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 12, 2012
Applying the 2011 St Gallen panel of prognostic markers on a large single hospital cohort of consecutively treated primary operable breast cancersO Brouckaert, A Laenen, J Vanderhaegen, et al.
Acta Gastro-Enterologica Belgica|November 23, 2011
Familial adenomatous polyposis: clinical presentation, detection and surveillanceS Laurent, D Franchimont, J P Coppens, et al.
Targeted Oncology|May 13, 2016
An Adaptive Study to Determine the Optimal Dose of the Tablet Formulation of the PARP Inhibitor OlaparibJ Mateo, V Moreno, A Gupta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 2011
Stellate ganglion block for the management of hot flashes and sleep disturbances in breast cancer survivors: an uncontrolled experimental study with 24 weeks of follow-upK Haest, A Kumar, B Van Calster, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2011
Aromatase inhibitor-induced loss of grip strength is body mass index dependent: hypothesis-generating findings for its pathogenesisA Lintermans, B Van Calster, M Van Hoydonck, et al.
Breast Cancer Research and Treatment|January 11, 2007
Body mass index and HER-2 overexpression in breast cancer patients over 50 years of ageT Van Mieghem, K Leunen, N Pochet, et al.
Breast Cancer Research and Treatment|July 15, 2009
Prevalent breast cancer patients with a homozygous mutant status for CYP2D6*4: response and biomarkers in tamoxifen usersA S Dieudonné, D Lambrechts, B Claes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 2012
Prospective study to assess fluid accumulation and tenosynovial changes in the aromatase inhibitor-induced musculoskeletal syndrome: 2-year follow-up dataA Lintermans, A Laenen, B Van Calster, et al.
Breast Cancer Research and Treatment|August 10, 2007
Age interacts with the expression of steroid and HER-2 receptors in operable invasive breast cancerP Neven, B Van Calster, I Van den Bempt, et al.
Pageof 4